• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服抗原与生物黏附性可降解淀粉微粒后诱导分泌性和血清抗体反应。

Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles.

作者信息

Montgomery P C, Rafferty D E

机构信息

Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

出版信息

Oral Microbiol Immunol. 1998 Jun;13(3):139-49. doi: 10.1111/j.1399-302x.1998.tb00725.x.

DOI:10.1111/j.1399-302x.1998.tb00725.x
PMID:10093528
Abstract

Bioadhesive degradable starch microparticles were used to deliver antigen and immunoglobulin A (IgA)-enhancing cytokines to the oral mucosa. Degradable starch microparticle immunization groups consisted of rats dosed topically at the sublingual epithelium of the oral cavity, by subcutaneous injection in the vicinity of the major salivary glands or by oral intubation with degradable starch microparticles containing dinitrophenyl-bovine serum albumin +/- IL-5/IL-6 +/- penetration enhancer (alpha-lysophosphatidylcholine). Dinitrophenyl-bovine serum albumin was also adsorbed onto alum for salivary gland vicinity injection and administered to the oral cavity in soluble form. Animals were subjected to 3 immunization cycles, and sequential samples were assayed by radioimmunoassay for salivary IgA, tear IgA and serum IgG anti-dinitrophenyl antibodies after secondary and tertiary immunization. Salivary IgA responses were highest in degradable starch microparticle groups receiving penetration enhancer at 71 days post-secondary immunization and continued in one degradable starch microparticle((oral cavity) and two injected (salivary gland vicinity) groups for up to 88 days post-tertiary immunization. Long-term tear responses were also observed in degradable starch microparticle groups receiving penetration enhancer, but they dissipated before the salivary gland-alum responses following tertiary immunization. Serum IgG responses were most pronounced in salivary gland groups, but long-term low level responses were detectable in oral cavity groups receiving degradable starch microparticle formulations with penetration enhancer. Inclusion of IL-5 and IL-6 in oral cavity-delivered degradable starch microparticle formulations consistently enhanced tear IgA while only upregulating salivary IgA antibody responses at early time points post immunization. IL-5 and IL-6 did not enhance serum IgG antibodies in any group. These data indicate that bioadhesive degradable starch microparticles can be used as a vehicle to deliver antigen and cytokine signals to the oral cavity and, when delivered in combination with a penetration enhancer, can potentiate long-term salivary IgA responses.

摘要

生物黏附性可降解淀粉微粒被用于将抗原和免疫球蛋白A(IgA)增强细胞因子递送至口腔黏膜。可降解淀粉微粒免疫组由经口腔舌下上皮局部给药、在主要唾液腺附近皮下注射或经口插管给予含有二硝基苯基 - 牛血清白蛋白+/-白细胞介素 - 5/白细胞介素 - 6+/-渗透增强剂(α - 溶血磷脂酰胆碱)的可降解淀粉微粒的大鼠组成。二硝基苯基 - 牛血清白蛋白也吸附在明矾上用于唾液腺附近注射,并以可溶形式给予口腔。动物接受3个免疫周期,在二次和三次免疫后,通过放射免疫分析法对唾液IgA、泪液IgA和血清抗二硝基苯基抗体进行连续样本检测。在二次免疫后71天,接受渗透增强剂的可降解淀粉微粒组的唾液IgA反应最高,并且在三次免疫后长达88天,一个可降解淀粉微粒(口腔)组和两个注射(唾液腺附近)组仍持续存在。在接受渗透增强剂的可降解淀粉微粒组中也观察到长期的泪液反应,但在三次免疫后,它们在唾液腺 - 明矾反应之前就消失了。唾液腺组的血清IgG反应最为明显,但在接受含有渗透增强剂的可降解淀粉微粒制剂的口腔组中可检测到长期的低水平反应。在经口腔递送的可降解淀粉微粒制剂中加入白细胞介素 - 5和白细胞介素 - 6持续增强泪液IgA,而仅在免疫后的早期时间点上调唾液IgA抗体反应。白细胞介素 - 5和白细胞介素 - 6在任何组中均未增强血清IgG抗体。这些数据表明,生物黏附性可降解淀粉微粒可作为一种载体,将抗原和细胞因子信号递送至口腔,并且当与渗透增强剂联合递送时,可增强长期的唾液IgA反应。

相似文献

1
Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles.口服抗原与生物黏附性可降解淀粉微粒后诱导分泌性和血清抗体反应。
Oral Microbiol Immunol. 1998 Jun;13(3):139-49. doi: 10.1111/j.1399-302x.1998.tb00725.x.
2
Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system.一种可生物降解微粒抗原/细胞因子递送系统的制备与表征
Vaccine. 1996 Apr;14(6):532-8. doi: 10.1016/0264-410x(95)00196-8.
3
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.用含抗原的可生物降解微粒进行口服免疫后,分泌型IgA和全身性IgG抗体反应增强。
Immunology. 1992 May;76(1):164-8.
4
Induction of secretory immunity with bioadhesive poly (D,L-lactide-co-glycolide) microparticles containing Streptococcus sobrinus glucosyltransferase.用含有远缘链球菌葡糖基转移酶的生物黏附性聚(D,L-丙交酯-共-乙交酯)微粒诱导分泌性免疫
Oral Microbiol Immunol. 2000 Apr;15(2):124-30. doi: 10.1034/j.1399-302x.2000.150209.x.
5
Inductive pathways leading to rat tear IgA antibody responses.导致大鼠泪液IgA抗体反应的诱导途径。
Invest Ophthalmol Vis Sci. 1998 May;39(6):1005-11.
6
Novel polymer-grafted starch microparticles for mucosal delivery of vaccines.用于疫苗黏膜递送的新型聚合物接枝淀粉微粒
Immunology. 1996 May;88(1):162-8. doi: 10.1046/j.1365-2567.1996.d01-639.x.
7
In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses.白细胞介素5和6对大鼠泪液IgA抗体反应的体内佐剂效应。
Immunology. 1991 May;73(1):19-23.
8
Enhancement of rat tear IgA antibody responses following intranasal immunization with antigen and CpG ODN.经鼻用抗原和CpG寡脱氧核苷酸免疫后大鼠泪液IgA抗体反应增强。
Curr Eye Res. 2002 Mar;24(3):228-33. doi: 10.1076/ceyr.24.3.228.8298.
9
The effect of immunization route on rat serum and tear antibody responses to Chlamydia trachomatis.免疫途径对大鼠血清及泪液针对沙眼衣原体抗体反应的影响。
Reg Immunol. 1993 Mar-Apr;5(2):114-9.
10
[Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].通过肌肉注射途径进行靶向融合抗龋DNA疫苗免疫:小鼠实验
Zhonghua Yi Xue Za Zhi. 2004 May 2;84(9):754-9.

引用本文的文献

1
Novel vaccine development strategies for inducing mucosal immunity.诱导黏膜免疫的新型疫苗研发策略。
Expert Rev Vaccines. 2012 Mar;11(3):367-79. doi: 10.1586/erv.11.196.
2
Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.通过重组衣原体疫苗诱导阴道脱落和不孕的保护。
Vaccine. 2011 Jul 18;29(32):5276-83. doi: 10.1016/j.vaccine.2011.05.013. Epub 2011 May 24.